Immunopathology of hyperacute xenograft rejection in a swine-to-primate model

Transplantation

Volumn 52, Issue 2, 1991, Pages 214-220

  Platt, Jeffrey L ^a   Fischel, Richard J ^a   Matas, Arthur J ^a   Reif, Sally A ^a   Bolman, R Morton ^a   Bach, Fritz H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; IMMUNOGLOBULIN M;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT SYSTEM; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOPATHOLOGY; KIDNEY TRANSPLANTATION; MONKEY; NONHUMAN; PRIORITY JOURNAL; SWINE; XENOGRAFT;

ANIMAL; ANTIBODIES; BLOOD PLATELETS; COMPLEMENT ACTIVATION; COMPLEMENT PATHWAY, CLASSICAL; FIBRIN; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KIDNEY TRANSPLANTATION; MACACA MULATTA; MODELS, BIOLOGICAL; PERFUSION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SWINE; THROMBOSIS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0025838090     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199108000-00006     Document Type: Article

References (51)

1. Reemtsma K, McCracken BH, Schlegel JU, et al. Renal heterotransplantation in man. Ann Surg 1964; 160: 384.
2. Perper RJ, Najarian JS, Experimental renal heterotransplantation: I. In widely divergent species. Transplantation 1966; 4: 337.
3. Giles GR, Boehmig HJ, Lilly J, et al. Mechanism and modification of rejection of heterografts between divergent species. Transplant Proc 1970; 2: 522.
4. Auchincloss H. Xenogeneic transplantation. Transplantation 1988; 46: 1.
5. Reemtsma K. Xenotransplantation: a personal history. In: Hardy MA, ed. Xenograft 25. New York: Elsevier Science, 1989: 7.
6. Gewurz H, Clark DS, Cooper MD, Varco RL, Good RA. Effect of cobra venom-induced inhibition of complement activity on allograft and xenograft rejection reactions. Transplantation 1967; 5: 1296.
7. Mejia-Laguna JE, Martinez-Palomo A, Biro CE, Chavez B, Lopez-Soriano F, Garcia-Cornejo M. Morphologic study of the participation of the complement system in hyperacute rejection of renal xenotransplantation. Am J Pathol 1972; 69: 71.
8. Platt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11: 450.
9. Platt JL, Bach FH, Mechanisms of tissue injury in hyperacute xenograft rejection. In: Cooper DKC, Kemp E, Reemtsma K, White DJG, eds. Xenotransplantation (in press).
10. Kemp E, Steinbruchel D, Starklint H, Larsen S, Henriksen I, Diepernik H. Renal xenograft rejection: prolonging effect of captopril, ACE-inhibitors, prostacyclin and cobra venom factor. Transplant Proc 1987; 19: 4471.
11. Miyagawa S, Hirose H, Shirakura R, et al. The mechanism of discordant xenograft rejection. Transplantation 1988; 46: 825.
12. Johnston P, Lim S, Wright L, White D. Hyperacute xenograft rejection takes place in the complete absence of antibodies but requires the presence of functional complement. Transplant Proc 1991; 23: 877.
13. Rosenberg JC, Hawkins E, Rector F. Mechanisms of immunological injury during antibody-mediated hyperacute rejection of renal heterografts. Transplantation 1971; 11:151.
14. Colman RB, Habal M, Hollenberg NK, Birtch AG, Busch GJ. Hyperacute renal allograft rejection in the primate. Am J Pathol 1976; 82: 25.
15. Busch GJ, Martins ACP, Hollenberg NK, Moretz RC, Wilson RE, Colman RW. Successful short-term modification of hyperacute renal allograft rejection in the primate. Am J Pathol 1976; 82: 43.
16. Marceau JP, Hallenbeck GA, Zollman PE, Butler HC, Shorter RG. A comparison of autoplastic, allogeneic and xenogeneic perfusion of isolated kidneys. J Surg Res 1965; 5: 492.
17. Fischel RJ, Bolman RM, Platt JL, Najarian JS, Bach FH, Matas AJ. Removal of IgM anti-endothelial antibodies results in prolonged cardiac xenograft survival. Transplant Proc 1990; 22: 1077.
18. Fischel RJ, Platt JL, Matas AJ, et al. Prolonged survival of a discordant cardiac xenograft in a rhesus monkey. Transplant Proc 1991; 23: 589.
19. Cooper DKC, Human PA, Lexer G, et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 1988; 7: 238.
20. Platt JL, Turman MA, Noreen H, Fischel RJ, Bolman RM, Bach FH. An ELISA assay for xenoreactive natural antibodies. Transplantation 1990; 49: 1000.
21. Falk RJ, Dalmasso AP, Kim Y, et al. Neoantigen of the polymerized ninth component of complement: characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J Clin Invest 1983; 72: 560.
22. Platt JL, Michael AF. Immune cell populations in interstitial disease of the renal allograft. In: Kreis H, Droz D, eds. Renal transplant cytology. Milan: Wichtig Editore, 1984: 127.
23. Platt JL, LeBien TW, Michael AF. Stages of renal ontogenesis identified by monoclonal antibodies reactive with lymphohemo- poietic differentiation antigens. J Exp Med 1983; 157: 155.
24. Platt JL, Michael AF. Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine. J His- tochem Cytochem 1983; 31: 840.
25. Platt JL, Lindman BJ, Chen H, Spitalnik SL, Bach FH. Endothelial cell antigens recognized by xenoreactive human natural antibodies. Transplantation 1990; 50: 817.
26. Caine RY. Organ transplantation between widely disparate species. Transplant Proc 1970; 2: 550.
27. Hammer C. Isohemagglutinins and preformed natural antibodies in xenogeneic organ transplantation. Transplant Proc 1987; 19: 4443.
28. Perper RJ, Najarian JS, Experimental renal heterotransplantation: Passive transfer of transplantation immunity. Transplantation 1967; 5: 514.
29. Lexer G, Cooper DKC, Rose AG, et al. Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model. J Heart Transplant 1986; 5: 411.
30. Shons AR, Bien M, Jetzer T, Najarian JS. Techniques of in vivo plasma modification for the treatment of hyperactive rejection. Surgery 1973; 73: 28.
31. Van de Stadt J, Vendeville B, Weill B, et al. Discordant heart xenografts in the rat. Transplantation 1988; 45: 514.
32. Reding R, Davies HS, White LJ, et al. Effect of plasma exchange on guinea pig-to-rat heart xenografts. Transplant Proc 1989; 21: 534.
33. Alexandre GPJ, Gianello P, Latinne D, et al. Plasmapheresis and splenectomy in experimental renal xenotransplantation. In: Hardy MA, ed. Xenograft 25. New York: Elsevier Science, 1989: 259.
34. Platts-Mills TAE, Ishizaka K. Activation of the alternative pathway of human complement by rabbit cells. J Immunol 1974; 114: 348.
35. Pangburn MK, Muller-Eberhard HJ. The alternative pathway of complement. Springer Semin Immunopathol 1984; 7: 163.
36. Bach FH, Turman MA, Vercellotti GM, Platt JL, Dalmasso AP. Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplant Proc 1991; 23: 205.
37. Turman MA, Casali P, Notkins AL, Bach FH, Platt JL, Polyreactivity and antigen specificity of human xenoreactive serum natural antibodies and monoclonal antibodies. Transplantion (in press).
38. Platt JL, Vercellotti GM, Lindman B, Oegema TR Jr, Bach FH, Dalmasso AP. Release of heparan sulfate from endothelial cells: implications for pathogenesis of hyperacute rejection: J Exp Med 1990; 171: 1363.
39. Vercellotti GM, Platt JL, Bach FH, Dalmasso AP. Neutrophil adhesion to xenogeneic endothelium via C3bi. J Immunol 1991; 146: 730.
40. Hamilton KK, Hattori R, Esmon CT, Sims PJ. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrom- binase enzyme complex. J Biol Chem 1990; 265: 3809.
41. Friedl HP, Till GO, Ryan US, Ward PA. Mediator induced activation of xanthine oxidase in endothelial cells. FASEB J 1989; 3: 2512.
42. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163: 740.
43. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987; 84: 9238.
44. Pober JS. Cytokine-mediated activation of vascular endothelium. Am J Pathol 1988; 133: 426.
45. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA Jr, Los-kutoff DJ. Cytokine activation of vascular endothelium: effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 1988; 263: 5797.
46. Brett J, Gerlach H, Nawroth P, Steinberg S, Godman G, Stern D. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med 1989; 169: 1977.
47. Geng JG, Bevilacqua MP, Moore KL, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990; 343: 757.
48. Chopek MW, Simmons RL, Platt JL. ABO incompatible renal transplantation: initial immunopathologic evaluation. Transplant Proc 1987; 19: 4553.
49. Alexandre GPJ, Squifflet JP, De Bruyere M, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987; 19: 4538.
50. Bach FH, Platt JP. Transplantation: moving toward the 21st century. Basel: Karger contrib Nephrol 1990; 86:180.
51. Bryant RW, Granzow CA, Siegel MI, Egan RW, Billah MM: Phorbol esters increase synthesis of decay-accelerating factor, a phosphatidylinositol-anchored surface protein, in human endothelial cells. J Immunol 1990; 144: 593.